bioRxivCell BiologyPreprint
Cryo-ET reveals nanoscale thick filamentdisorganization in MYH7 P710R hypertrophiccardiomyopathy cardiomyocytes
Magda ZaoralováiD, Joseph YonilesiD, Prerna GiriiD, Richard G. HeldiD, Alison Schroer Vander RoestiD, Peter D. DahlbergiD, Daniel BernsteiniD, Alexander R. DunniD, Leeya EngeliD
Abstract
Hypertrophic cardiomyopathy (HCM) is the most common monogenic inherited heart disease and is a major cause of sudden death in individuals under 35 years of age. HCM is associated with progressive tissue-level disarray and subcellular disorganization in individual cardiomyocytes. Mutations in {beta}-cardiac myosin (MYH7), the second most common genetic cause of HCM, commonly result in changes in sarcomeric force production, but how this leads to altered cell- and tissue-level organization is unclear. Here, we use cryo-electron tomography (cryo-ET) to bridge the molecular and cellular scales by visualizing the nanoscale organization of individual myosin-containing thick filaments within sarcomeres of human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs). Compared to isogenic wild-type controls, hiPSC-CMs expressing P710R MYH7 exhibit pronounced disruption of the hexagonal packing of thick filaments within individual sarcomeres, which would be difficult to visualize using conventional light microscopy or even room-temperature electron microscopy. We also observe ribosome infiltration into areas of sarcomeric disorder for both wild-type and P710R MYH7 hiPSC-CMs, suggesting that disordered regions may be sites of local proteostasis or remodeling. Together, these data illuminate how altered myosin activity can propagate to yield dramatic changes in sarcomeric organization in HCM.
- organism: human
- assay: cryo-EM
- research focus: cell type annotation
- research focus: spatial domain detection
- approach: microscopy & imaging analysis
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Hypertrophic cardiomyopathy β-cardiac myosin mutation (P710R) leads to hypercontractility by disrupting super-relaxed state: multiscale measurements and computational modeling
A. S. Vander Roest, C. Liu, … D. Bernstein·bioRxiv·Nov 10, 2020
- A contraction stress model of hypertrophic cardiomyopathy due to thick filament sarcomere mutations
R. Cohn, K. Thakar, … J. T. Hinson·bioRxiv·Sep 4, 2018
- HCM-associated mutations in MYH6/7 drive pathologic expression of TGF-β1 in cardiomyocytes within weeks of developmental specification
Jeanne Hsieh, Megan A. L. Hall, … Brenda M. Ogle·bioRxiv·Aug 8, 2024
- Myosin Heavy Chain Converter Domain Mutations Drive Early-Stage Changes in Extracellular Matrix Dynamics in Hypertrophic Cardiomyopathy
J. Hsieh, K. Becklin, … B. M. Ogle·bioRxiv·Apr 5, 2022
- Multi-scale models reveal hypertrophic cardiomyopathy MYH7 G256E mutation drives hypercontractility and elevated mitochondrial respiration
Soah Lee, Alison Schroer Vander Roest, … Daniel Bernstein·bioRxiv·Jun 8, 2023
- Hypertrophic cardiomyopathy mutations at the folded-back sequestered β-cardiac myosin S1-S2 and S1-S1 interfaces release sequestered heads and increase myosin enzymatic activity
A. S. Adhikari, D. V. Trivedi, … K. M. Ruppel·bioRxiv·Jan 31, 2019